"Créé en 1993, l’Hôpital privé Saint-Martin de Caen, établissement du groupe Ramsay Santé, naît de la fusion entre trois cliniques de l’agglomération caennaise : Saint Pierre, St Joseph et St Martin. Un an plus tard, il intègre le Groupe Ramsay Santé. Avec 35 000 hospitalisations par an, il est aujourd’hui le leader régional de l’hospitalisation privée en chirurgie et en chirurgie ambulatoire."

During the past decade, Hôpital Privé saint Martin conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 2 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Privé saint Martin" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "Medtronic" with 3 trials sponsored, "Ramsay Générale de Santé" with 3 trials sponsored, "Biotronik AG" with 1 trials sponsored and "Cardiac Dimensions Pty Ltd" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Privé saint Martin" #1 collaborator was "European Clinical Trial Experts Network" with 2 trials as a collaborator, "Pharmaceutical Research Associates" with 2 trials as a collaborator, "B.Braun Vascular Systems, Berlin, Germany" with 1 trials as a collaborator, "Biotronik France" with 1 trials as a collaborator and "Dr Céline FAURE" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Privé saint Martin" are "Coronary Artery Disease" (3 trials), "Heart Failure" (3 trials), "Coronary Heart Disease" (2 trials), "Myocardial Ischemia" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Hôpital Privé saint Martin" in a lesser frequency.

Most popular intervention types in "Hôpital Privé saint Martin" are "Device" (9 trials), "Other" (4 trials), "Procedure" (4 trials), "Drug" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anesthesia" (1 trials), "Angioplasty (PROMUS Element™, and Xience™ Prime stent)" (1 trials), "Angioplasty with D images" (1 trials), "Bivalirudin" (1 trials) and "CARILLON Mitral Contour System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Privé saint Martin" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Privé saint Martin". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Hôpital Privé saint Martin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Privé saint Martin, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".